Literature DB >> 19636554

Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).

Marta Anna Sobas, Natalia Alonso Vence, Jose Diaz Arias, Angeles Bendaña Lopez, Maximo Fraga Rodriguez, Jose Luis Bello Lopez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19636554     DOI： 10.1007/s00277-009-0795-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  15 in total

1.  HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.

Authors:  Maria M Sbenghe; Emmanuel Besa; Amit Mahipal; Alina Dulau Florea; Paul Bray; Jaime Caro
Journal:  Oncologist       Date:  2012

2.  Successful treatment of multicentric Castleman's disease accompanying myeloma with bortezomib.

Authors:  Afaq Ahmad Khan; Fouzia Siraj; Manorama Bhargava; Shyam Aggarwal
Journal:  BMJ Case Rep       Date:  2012-12-20

Review 3.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

Review 4.  How I treat POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

Review 5.  Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

Authors:  Satoshi Kuwabara; Angela Dispenzieri; Kimiyoshi Arimura; Sonoko Misawa; Chiaki Nakaseko
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 6.  Biologic Agents in the Treatment of Multicentric Castleman Disease.

Authors:  Konstantinos Kapriniotis; Savvas Lampridis; Sofoklis Mitsos; Davide Patrini; David R Lawrence; Nikolaos Panagiotopoulos
Journal:  Turk Thorac J       Date:  2018-10-01

7.  Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.

Authors:  Yoshimi Ishii; Etsuko Yamazaki; Yasufumi Ishiyama; Eri Yamamoto; Yukako Hattori; Maki Hagihara; Naoto Tomita; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2013-10-29       Impact factor: 2.490

Review 8.  Multicentric Castleman's disease: a challenging diagnosis.

Authors:  Györgyi Műzes; Ferenc Sipos; Judit Csomor; Lídia Sréter
Journal:  Pathol Oncol Res       Date:  2013-03-21       Impact factor: 3.201

9.  Coexistence of Hodgkin's Lymphoma and Castleman's Disease: A Case Report with Successful Response to Chemotherapy and Radiotherapy.

Authors:  Amina Mohtaram; Mohammed Afif; Tanae Sghiri; Amal Rami; Rachida Latib; Fouad Kettani; Meryam Ben Ameur El Youbi; Saber Boutayeb; Tayeb Kebdani; Noureddine Benjaafar; Imane Aaribi; Hassan Errihani
Journal:  Case Rep Oncol Med       Date:  2013-12-05

Review 10.  Idiopathic multicentric Castleman's disease: a systematic literature review.

Authors:  Amy Y Liu; Christopher S Nabel; Brian S Finkelman; Jason R Ruth; Razelle Kurzrock; Frits van Rhee; Vera P Krymskaya; Dermot Kelleher; Arthur H Rubenstein; David C Fajgenbaum
Journal:  Lancet Haematol       Date:  2016-03-17       Impact factor: 18.959
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.